Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stocks, par value $0,0001 per share
-
Shares outstanding
-
58,548,563
-
Total 13F shares
-
19,002,884
-
Share change
-
+3,338,570
-
Total reported value
-
$964,589,936
-
Price per share
-
$50.84
-
Number of holders
-
62
-
Value change
-
+$187,867,257
-
Number of buys
-
41
-
Number of sells
-
34
Institutional Holders of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) as of Q1 2021
As of 31 Mar 2021,
BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) was held by
62 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,002,884 shares.
The largest 10 holders included
FMR LLC, Soleus Capital Management, L.P., Cormorant Asset Management, LP, WELLINGTON MANAGEMENT GROUP LLP, Farallon Capital Management, L.L.C., JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, BlackRock Inc., BAKER BROS. ADVISORS LP, and BOXER CAPITAL, LLC.
This page lists
62
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.